Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers. [electronic resource]
Producer: 20100303Description: 484-93 p. digitalISSN:- 1873-2518
- Adolescent
- Adult
- Antibodies, Neutralizing -- immunology
- Antibody Formation -- immunology
- Antigens, Viral -- immunology
- Cytomegalovirus -- immunology
- Cytomegalovirus Vaccines -- administration & dosage
- Double-Blind Method
- Flow Cytometry
- Humans
- Immunity, Cellular -- immunology
- Middle Aged
- Models, Biological
- T-Lymphocytes -- immunology
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.